Published in Br Med J on June 30, 1979
Atenolol in essential hypertension during pregnancy. BMJ (1990) 1.39
Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart (2003) 0.99
Treatment of cardiovascular diseases. Br Med J (Clin Res Ed) (1987) 0.78
Anti-hypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J (1981) 0.75
Emergency aortic valve replacement and Caesarian section in a primigravida with severe aortic stenosis: a case report. Heart Asia (2011) 0.75
Hypertrophic cardiomyopathy in pregnancy. J R Soc Med (1983) 0.75
Propranolol administration during pregnancy: effects on the fetus. J Pediatr (1975) 1.79
Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.56
The effect of propranolol on the onset of breathing at birth. Br J Anaesth (1969) 1.44
Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.28
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
The microbiology and pathogenesis of infective endocarditis. Br Heart J (1983) 3.36
The cardiomyopathies. Br Heart J (1972) 3.14
Screening for atrial fibrillation in primary care. Heart (1998) 3.02
Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease. Br Heart J (1977) 2.68
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet (1991) 2.36
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet (1994) 2.25
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
Regression of primary pulmonary hypertension. Br Heart J (1976) 2.03
Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91
Eosinophilia and heart disease. Br Heart J (1977) 1.90
Infective endocarditis. Br J Hosp Med (1980) 1.88
Echocardiography of the mitral valve in aortic valve disease. Br Heart J (1971) 1.86
Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86
Assessment of site and severity in congenital aortic stenosis. Br Heart J (1967) 1.83
Right ventricular dilated cardiomyopathy. Br Heart J (1984) 1.74
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Cadiovascular complications of homozygous familial hypercholesterolaemia. Br Heart J (1980) 1.69
Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol (1992) 1.66
Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet (1992) 1.65
Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J (1971) 1.63
Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62
The bowel, the genitourinary tract, and infective endocarditis. Br Heart J (1984) 1.62
Congenital fistula between the aorta and left atrium. Br Heart J (1987) 1.61
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.56
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Objective assessment of treatment in severe angina. Br Med J (1979) 1.53
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Mechanism of mitral regurgitation in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.48
Clinical definitions and classification of cardiomyopathies. Postgrad Med J (1972) 1.47
Magnitude of myocardial dysfunction is greater in painful than in painless myocardial ischemia: an exercise echocardiographic study. J Am Coll Cardiol (1995) 1.44
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ (1995) 1.44
Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am J Cardiol (1991) 1.43
Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. J Thorac Cardiovasc Surg (1981) 1.42
Pregnancy in a patient with a mitral-valve prosthesis. Lancet (1968) 1.41
Factors that influence the outcome of primary pulmonary hypertension. Br Heart J (1986) 1.41
The diagnostic significance of reciprocal ST segment depression in acute myocardial infarction. Q J Med (1989) 1.40
Dental prophylaxis for endocarditis. Lancet (1992) 1.39
Pregnancy complicated by cardiac valvular disease and hypertension. Problems of management. Chest (1991) 1.38
Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest (1995) 1.37
Prediction of outcome in dilated cardiomyopathy. Br Heart J (1987) 1.35
Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol (1980) 1.30
Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy. Br Med J (1968) 1.28
Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation (1995) 1.27
Outcome of pregnancy in women with valve prostheses. Br Heart J (1994) 1.27
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
Selective coronary arteriography. A review of 18 months' experience. Clin Radiol (1970) 1.25
Echocardiographic features of eosinophilic endomyocardial disease. Br Heart J (1982) 1.24
Clinical recognition of the cardiomyopathies. Circ Res (1974) 1.24
Transplantation of the heart. Am Heart J (1969) 1.23
Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol (1986) 1.21
Hydralazine in the management of left ventricular failure. Am J Cardiol (1979) 1.21
Urgent aortic-valve replacement for acute aortic regurgitation due to infective endocarditis. Lancet (1971) 1.20
Medical insurance and the use of health care services by the elderly. J Health Econ (1997) 1.18
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J (1973) 1.17
Myocardial infarction with normal coronary angiogram. Possible mechanism of smoking risk in coronary artery disease. Br Heart J (1980) 1.16
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J (1974) 1.16
Incidence, mortality and prevention of infective endocarditis. J R Coll Physicians Lond (1986) 1.15
Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol (1992) 1.13
Assessment of long-term plasma exchange for familial hypercholesterolaemia. Br Heart J (1980) 1.12
Significance of abnormal electrocardiograms in highly trained athletes. Am J Cardiol (1982) 1.12
Successful surgical treatment of two patients with eosinophilic endomyocardial disease. Br Heart J (1981) 1.12
QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol (1992) 1.11
The functional defect in amyloid heart disease. The "stiff heart" syndrome. Am J Cardiol (1975) 1.09
Assessment of right ventricular function and anatomy using peripheral vein infusion of krypton 81m. Br J Radiol (1983) 1.08
After the infarct. Br Med J (Clin Res Ed) (1983) 1.07
Perfusion lung scanning in obliterative pulmonary hypertension. Br Heart J (1973) 1.06
The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation (1982) 1.06
Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. Br Heart J (1977) 1.06
Pulmonary valve stenosis without ventricular septal defect: results of surgery. Thorax (1966) 1.04
Pregnancy after surgical correction of tetralogy of Fallot. Br Med J (Clin Res Ed) (1982) 1.02
Cross sectional echocardiographic assessment of the aortic root and coronary ostial stenosis in familial hypercholesterolaemia. Br Heart J (1983) 1.02
Long-term complications of valve replacement. Br Med J (Clin Res Ed) (1982) 1.02
Course of patients discharged early after myocardial infarction. Br Med J (1976) 1.01
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J (1994) 1.01
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med (1992) 1.01
Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart (1999) 1.00
Q waves and coronary arteriography in cardiomyopathy. Br Heart J (1972) 0.99
Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med (1989) 0.98
The relation between function and causation in cardiomyopathy. Postgrad Med J (1975) 0.98
Successful repair of left ventricular aneurysm and ventricular septal defect after indirect injury. Lancet (1965) 0.97
Different mechanisms for the relief of angina after coronary bypass surgery. Physiological versus anatomical assessment. Br Heart J (1984) 0.97
Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Br Heart J (1990) 0.97
Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia. Br Med J (Clin Res Ed) (1981) 0.96
Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J (1987) 0.96
Percutaneous laser-assisted coronary angioplasty. Lancet (1986) 0.95
Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart (1999) 0.95
Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol (1993) 0.95
Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol (1992) 0.95
Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J (1994) 0.94
Antibiotic prophylaxis and infective endocarditis. Lancet (1992) 0.94
Management of aortic left ventricular tunnel. Br Heart J (1985) 0.93
Ventricular septal defect and aortic regurgitation. Thorax (1969) 0.93
Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br Heart J (1984) 0.93